Literature DB >> 25596358

Search for Microorganisms in Men with Urologic Chronic Pelvic Pain Syndrome: A Culture-Independent Analysis in the MAPP Research Network.

J Curtis Nickel1, Alisa Stephens2, J Richard Landis2, Jun Chen3, Chris Mullins4, Adrie van Bokhoven5, M Scott Lucia5, Rachael Melton-Kreft6, Garth D Ehrlich7.   

Abstract

PURPOSE: We used next-generation, state-of-the-art, culture independent methodology to survey urine microbiota of males with urologic chronic pelvic pain syndrome and control participants enrolled in the MAPP Network to investigate a possible microbial etiology.
MATERIALS AND METHODS: Male patients with urologic chronic pelvic pain syndrome and matched controls were asked to provide initial, midstream and post-prostatic massage urine specimens. Specimens were analyzed with Ibis T-5000 Universal Biosensor technology to provide comprehensive identification of bacterial and select fungal species. Differences between urologic chronic pelvic pain syndrome and control study participants for the presence of species or species variation in a higher taxonomic grouping (genus) were evaluated using permutational multivariate analysis of variance and logistic regression.
RESULTS: Initial and midstream urine specimens were obtained from 110 (post-prostatic massage urine in 67) participants with urologic chronic pelvic pain syndrome and 115 (post-prostatic massage urine in 62) controls. Overall 78, 73 and 54 species (42, 39 and 27 genera) were detected in initial, midstream and post-prostatic massage urine specimens, respectively. Mean (SD) initial, midstream and post-prostatic massage urine species count per person was 1.62 (1.28), 1.38 (1.36) and 1.33 (1.24) for cases, and 1.75 (1.32), 1.23 (1.15) and 1.56 (0.97) for controls, respectively. Overall species and genus composition differed significantly between participants with urologic chronic pelvic pain syndrome and controls in initial stream urine (p=0.002 species level, p=0.004 genus level), with Burkholderia cenocepacia overrepresented in urologic chronic pelvic pain syndrome. No significant differences were observed at any level in midstream or post-prostatic massage urine samples.
CONCLUSIONS: Assessment of baseline culture-independent microbiological data from male subjects enrolled in the MAPP Network has identified overrepresentation of B. cenocepacia in urologic chronic pelvic pain syndrome. Future studies are planned to further evaluate microbiota associations with variable and changing urologic chronic pelvic pain syndrome symptom patterns.
Copyright © 2015 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  chronic pain; infection; microbiota; pelvic pain; prostatitis

Mesh:

Year:  2015        PMID: 25596358      PMCID: PMC4475477          DOI: 10.1016/j.juro.2015.01.037

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  24 in total

Review 1.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

2.  Uropathogenic Escherichia coli induces chronic pelvic pain.

Authors:  Charles N Rudick; Ruth E Berry; James R Johnson; Brian Johnston; David J Klumpp; Anthony J Schaeffer; Praveen Thumbikat
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

3.  Prevalence of corynebacterial 16S rRNA sequences in patients with bacterial and "nonbacterial" prostatitis.

Authors:  M A Tanner; D Shoskes; A Shahed; N R Pace
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

4.  Detection of bacterial signal by 16S rRNA polymerase chain reaction in expressed prostatic secretions predicts response to antibiotic therapy in men with chronic pelvic pain syndrome.

Authors:  D A Shoskes; A R Shahed
Journal:  Tech Urol       Date:  2000-09

5.  Prokaryotic DNA sequences in patients with chronic idiopathic prostatitis.

Authors:  J N Krieger; D E Riley; M C Roberts; R E Berger
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

6.  Identification of Burkholderia cenocepacia strain H111 virulence factors using nonmammalian infection hosts.

Authors:  Stephan Schwager; Kirsty Agnoli; Manuela Köthe; Friederike Feldmann; Michael Givskov; Aurelien Carlier; Leo Eberl
Journal:  Infect Immun       Date:  2012-10-22       Impact factor: 3.441

7.  A case of prostatitis due to Burkholderia pseudomallei.

Authors:  Jorge M Arzola; Joshua S Hawley; Crystal Oakman; Rafael V Mora
Journal:  Nat Clin Pract Urol       Date:  2007-02

8.  Coagulase-negative staphylococcus in chronic prostatitis.

Authors:  J C Nickel; J W Costerton
Journal:  J Urol       Date:  1992-02       Impact factor: 7.450

9.  Bacterial localization in antibiotic-refractory chronic bacterial prostatitis.

Authors:  J C Nickel; J W Costerton
Journal:  Prostate       Date:  1993       Impact factor: 4.104

10.  The MAPP research network: a novel study of urologic chronic pelvic pain syndromes.

Authors:  J Quentin Clemens; Chris Mullins; John W Kusek; Ziya Kirkali; Emeran A Mayer; Larissa V Rodríguez; David J Klumpp; Anthony J Schaeffer; Karl J Kreder; Dedra Buchwald; Gerald L Andriole; M Scott Lucia; J Richard Landis; Daniel J Clauw
Journal:  BMC Urol       Date:  2014-08-01       Impact factor: 2.264

View more
  29 in total

Review 1.  The inflammatory microenvironment and microbiome in prostate cancer development.

Authors:  Karen S Sfanos; Srinivasan Yegnasubramanian; William G Nelson; Angelo M De Marzo
Journal:  Nat Rev Urol       Date:  2017-10-31       Impact factor: 14.432

Review 2.  Gut microbiome and chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Hans C Arora; Charis Eng; Daniel A Shoskes
Journal:  Ann Transl Med       Date:  2017-01

3.  The impact of microbiome in urological diseases: a systematic review.

Authors:  Joseph K M Li; Peter K F Chiu; Chi-Fai Ng
Journal:  Int Urol Nephrol       Date:  2019-07-12       Impact factor: 2.370

Review 4.  [The role of the microbiome in urology].

Authors:  G Magistro; J Marcon; L Eismann; Y Volz; C G Stief
Journal:  Urologe A       Date:  2020-12       Impact factor: 0.639

Review 5.  Urologic chronic pelvic pain syndrome: insights from the MAPP Research Network.

Authors:  J Quentin Clemens; Chris Mullins; A Lenore Ackerman; Tamara Bavendam; Adrie van Bokhoven; Benjamin M Ellingson; Steven E Harte; Jason J Kutch; H Henry Lai; Katherine T Martucci; Robert Moldwin; Bruce D Naliboff; Michel A Pontari; Siobhan Sutcliffe; J Richard Landis
Journal:  Nat Rev Urol       Date:  2019-03       Impact factor: 14.432

6.  Urine: Waste product or biologically active tissue?

Authors: 
Journal:  Neurourol Urodyn       Date:  2018-02-21       Impact factor: 2.696

Review 7.  Anorectal and Pelvic Pain.

Authors:  Adil E Bharucha; Tae Hee Lee
Journal:  Mayo Clin Proc       Date:  2016-10       Impact factor: 7.616

Review 8.  Chronic prostatitis/chronic pelvic pain syndrome: a review of evaluation and therapy.

Authors:  A S Polackwich; D A Shoskes
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-03-08       Impact factor: 5.554

9.  Assessment of the Lower Urinary Tract Microbiota during Symptom Flare in Women with Urologic Chronic Pelvic Pain Syndrome: A MAPP Network Study.

Authors:  J Curtis Nickel; Alisa Stephens; J Richard Landis; Chris Mullins; Adrie van Bokhoven; M Scott Lucia; Garth D Ehrlich
Journal:  J Urol       Date:  2015-09-26       Impact factor: 7.450

Review 10.  Gram-Positive Uropathogens, Polymicrobial Urinary Tract Infection, and the Emerging Microbiota of the Urinary Tract.

Authors:  Kimberly A Kline; Amanda L Lewis
Journal:  Microbiol Spectr       Date:  2016-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.